“…However, the current study may be underpowered to detect significance given the low patient number and the low incidence of complications in this study. In referring to previous large studies with reported readmission rates ranging between 1.7 and 5.6%, reoperation between 1.02 and 2.49%, overall complication rates between 1.9 and 3.76%, and mortality rates up to 0.94% [ 9 – 11 , 14 , 19 ], our results fall within these ranges and therefore meet the safety standards.…”